Search Results - "Pectasides, D"

Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature by Kamposioras, K, Pentheroudakis, G, Pectasides, D, Pavlidis, N

“…Abstract Introduction Although more than 90% of melanomas have a cutaneous origin, occasionally it is discovered as a secondary deposit without evident primary…”
Get full text

Germ cell tumors of the ovary by Pectasides, D, Pectasides, E, Kassanos, D

“…Summary Purpose Malignant ovarian germ cell tumors (MOGCTS) are rare but curable at all stages of disease. This review gives an outline of the management of…”
Get full text

Pancreatic cancer: Current and future treatment strategies by Pliarchopoulou, K, Pectasides, D

“…Summary Pancreatic cancer is a disease with a high mortality rate and short survival, as a result of the high incidence of metastatic disease at diagnosis, the…”
Get full text

Granulosa cell tumor of the ovary by Pectasides, D, Pectasides, E, Psyrri, A

“…Summary Ovarian granulosa cell tumors (GCTs) are uncommon neoplasms that arise from the sex-cord stromal cells of the ovary. GCTs are characterized by long…”
Get full text

Chemotherapy for recurrent cervical cancer by Pectasides, D, Kamposioras, K, Papaxoinis, G, Pectasides, E

“…Summary Purpose Cervical cancer is the second most common cancer of women worldwide and one of the leading cause of death in relative young women. This review…”
Get full text

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study by Psyrri, A., Kalogeras, K.T., Kronenwett, R., Wirtz, R.M., Batistatou, A., Bournakis, E., Timotheadou, E., Gogas, H., Aravantinos, G., Christodoulou, C., Makatsoris, T., Linardou, H., Pectasides, D., Pavlidis, N., Economopoulos, T., Fountzilas, G.

“…The ubiquitin–proteasome system (UPS) plays a pivotal role in tumorigenesis. Components of the UPS have recently been implicated in breast cancer progression…”
Get full text

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer by Razis, E., Bobos, M., Kotoula, V., Eleftheraki, A. G., Kalofonos, H. P., Pavlakis, K., Papakostas, P., Aravantinos, G., Rigakos, G., Efstratiou, I., Petraki, K., Bafaloukos, D., Kostopoulos, I., Pectasides, D., Kalogeras, K. T., Skarlos, D., Fountzilas, G.

“…Trastuzumab (T) is effective in metastatic breast cancer (MBC) with HER2 overexpression and/or amplification, but resistance to T develops in a significant…”
Get full text

Merkel cell cancer of the skin by Pectasides, D, Pectasides, M, Economopoulos, T

“…Merkel cell carcinoma (MCC) is a rare malignant cutaneous tumor of the elderly with rapidly growing skin nodules found predominantly on sun-exposed areas of…”
Get full text

Prognostic significance of IGF-1 signaling pathway in patients with advanced non-small cell lung cancer by Kotsantis, I., Economopoulou, P., Psyrri, A., Maratou, E., Pectasides, D., Gogas, H., Kentepozidis, N., Mountzios, G., Dimitriadis, G., Giannouli, S.

Get full text

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03) by Bamias, A., Dafni, U., Karadimou, A., Timotheadou, E., Aravantinos, G., Psyrri, A., Xanthakis, I., Tsiatas, M., Koutoulidis, V., Constantinidis, C., Hatzimouratidis, C., Samantas, E., Visvikis, A., Chrisophos, M., Stravodimos, K., Deliveliotis, C., Eleftheraki, A., Pectasides, D., Fountzilas, G., Dimopoulos, M.A.

“…The combinations of methotrexate, vinblastine, Adriamycin, cisplatin (Pharmanell, Athens, Greece) (MVAC) or gemcitabine, cisplatin (GC) represent the standard…”
Get full text

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial by Pliarchopoulou, K., Kalogeras, K. T., Kronenwett, R., Wirtz, R. M., Eleftheraki, A. G., Batistatou, A., Bobos, M., Soupos, N., Polychronidou, G., Gogas, H., Samantas, E., Christodoulou, C., Makatsoris, T., Pavlidis, N., Pectasides, D., Fountzilas, G.

“…Purpose RACGAP1 is a Rac GTPase-activating protein involved in cell growth regulation, cell transformation and metastasis. The aim of the present study was to…”
Get full text

Gastric Metastases Originating from Breast Cancer: Report of 8 Cases and Review of the Literature by Pectasides, D, Psyrri, A, Pliarchopoulou, K, Floros, T, Papaxoinis, G, Skondra, M, Papatsibas, G, Macheras, A, Athanasas, G, Arapantoni-Datioti, P, Economopoulos, T

“…Background: Breast cancer metastasis to the stomach is rare. It is very important to distinguish a breast cancer metastasis to the stomach from a primary…”
Get full text

Evaluation of the efficacy and safety of everolimus as a first-line treatment in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors by Koumarianou, A., Pectasides, D.G., Manousou, K., Dionysopoulos, D., Kaltsas, G.A., Kolomodi, D., Poulios, C., Skondra, M., Samantas, E., Pentheroudakis, G., Fountzilas, G.

Get full text

A phase II window of opportunity study of preoperative olaparib (O) with cisplatin (C) or durvalumab (D) or olaparib alone in in patients with operable squamous cell head and neck carcinoma (HNSCC) (OPHELIA) by Psyrri, A., Economopoulou, P., Kotsantis, I., Koutsodontis, G., Cheila, M., Papaxoinis, G., Pectasides, D.G., Fountzilas, G., Krikoni, L., Souliotis, V.

Get full text

The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center by Koskinas, J.S, Deutsch, M, Adamidi, S, Skondra, M, Tampaki, M, Alexopoulou, A, Manolakopoulos, S, Pectasides, D

“…Abstract Introduction/aim Patients who present HBV reactivation during immunosuppressive treatment are prone to develop life threatening decompensation of the…”
Get full text

randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer by Bamias, Aristotelis, Karina, M, Papakostas, P, Kostopoulos, I, Bobos, M, Vourli, G, Samantas, E, Christodoulou, Ch, Pentheroudakis, G, Pectasides, D, Dimopoulos, M. A, Fountzilas, G

“…The optimal adjuvant treatment for gastric cancer remains controversial. We compared the efficacy of a docetaxel and platinum adjuvant chemotherapy regimen, in…”
Get full text

Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients by Pectasides, D, Pectasides, E, Papaxoinis, G, Andreadis, C, Papatsibas, G, Fountzilas, G, Pliarchopoulou, K, Macheras, A, Aravantinos, G, Economopoulos, T

“…Abstract Objective The objective of this retrospective study was to determine the clinical outcomes of patients with primary fallopian tube carcinoma (PFTC)…”
Get full text

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group by BAMIAS, A, ARAVANTINOS, G, PAPAKASTAS, P, GIKA, D, KOUROUSIS, C, KOUTRAS, A, PAPADIMITRIOU, C, BAMIAS, C, KOSMIDIS, P, DIMOPOULOS, M. A, DELIVELIOTIS, C, BAFALOUKOS, D, KALOFONOS, C, XIROS, N, ZERVAS, A, MITROPOULOS, D, SAMANTAS, E, PECTASIDES, D

“…The combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) represents the standard regimen for inoperable or metastatic urothelial cancer,…”
Get full text

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer by Pectasides, D, Xiros, N, Papaxoinis, G, Pectasides, E, Sykiotis, C, Koumarianou, A, Psyrri, A, Gaglia, A, Kassanos, D, Gouveris, P, Panayiotidis, J, Fountzilas, G, Economopoulos, T

“…Abstract Objectives The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent…”
Get full text

Systemic therapy in metastatic or recurrent endometrial cancer by Pectasides, D, Pectasides, E, Economopoulos, T

“…Summary Endometrial cancer is one of the most common gynecologic malignancies. In patients with advanced or recurrent endometrial cancer survival is greatly…”
Get full text